Insight 20223
August 31 – September 3 in Berlin
PhD student

Hannah Douglass, MSc.

Centre for Psychedelic Research, Imperial College London

Hannah is a third year PhD Student at the Centre for Psychedelic Research, Imperial College London. She is currently acting as the clinical trial coordinator for the ongoing Psilocybin as a Treatment for Anorexia Nervosa pilot study. Her PhD research focuses on the safety, feasibility and efficacy of this treatment, in addition to the effects of psilocybin on neuroplasticity, cognitive flexibility and interoceptive awareness in this population. She is passionate about the ethics surrounding this area of research, in particular participant well-being and care, and the inclusion of voices from those with lived experience in study design. Her background is in neuropsychopharmacology, having received a BSc in Pharmacology from the University of Leeds and an MSc in Translational Neuroscience from Imperial College London.
Go to Top